Global Study Links 12% of 2024 Cancer Cases to Preventable Infections

A global analysis published in The Lancet Oncology estimates that 2.3 million cancer cases worldwide in 2024, representing 12% of all cases, were attributable to preventable infections. The study highlights the significant role of infectious agents, primarily Helicobacter pylori and HPV, as modifiable risk factors, suggesting that effective infection control measures and vaccinations could substantially reduce the global cancer burden.